Estimate of the HIV-1 prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in reducing perinatal transmission;Estimacion de la prevalencia de infeccion por VIH-1 en la embarazada y efectividad de la zidovudina administrada durante la gestacion en la prevencion de la transmision vertical

Medicina Clinica

Volumn 114, Issue 8, 2000, Pages 286-291

  Ramos Amador, José Tomás ^a   Ruiz Contreras, Jésus ^a   Bastero, Rafael ^a   Barrio, Carmen ^a   Moreno, Pilar ^a   Delgado, Rafael ^a   Muñoz, Eloy ^a   Jiménez, Jesús ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Human immunodeficiency virus type 1 (HIV 1); Perinatal transmission; Zidovudine

Indexed keywords

ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EARLY DIAGNOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MONOTHERAPY; PERINATAL INFECTION; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADOLESCENT; ADULT; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; MALE; NEWBORN; PREGNANCY COMPLICATION; PREVALENCE; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROSPECTIVE STUDIES; ZIDOVUDINE;

EID: 0034603275     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71271-1     Document Type: Article

References (37)

1. Boletín epidemialógico de la comunidad de Madrid. Vigilancia epidemiólogica del sida en España. Informe trimestral no. 3, 1997.
2. Peckham C, Gibb D, Current concepts: mother to child transmission of the human immunodeficiency virus. N Engl J Med 1995; 333: 297-302.
3. Scarlatti G. Pediatric HIV infection. Lancet 1996; 348: 863-868.
4. Mofenson L. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis 1994; 5: 252-255.
5. Blanche S, Mayaux MJ, Rouzioux C, Teglas JP, Firtion G, Monpoux F et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994; 330: 308-312.
6. Dickover RE, Garratly EM, Herman SA, Sim MS, Plaeger S, Boyer PJ et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. JAMA 1996, 275: 599-605.
7. European Collaborative Study. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996; 10: 1675-1681.
8. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C et al. Obstetrical factors and the transmission of human immunodeficicency virus type 1 from mother to child N Engl J Med 1996; 334: 1617-1623.
9. Tovo PA, De Martino M, Gabiano C, Galli L, Capello N, Ruga E et al. Mode of delivery and gestational age influence perinatal HIV-1 transmission. J Acq Immune Def Syndr Hum Retrovirol 1996; 11: 88-94.
10. Kuhn L, Abrams EJ, Matheson PB, Thomas PA, Lambert G, Bamji M et al. Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. AIDS 1997;11: 429-435.
11. Maguire A, Sánchez E, Fortuny C, Casabona J, and the Working Group on HIV-1 vertical transmission in Catalonia. Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of Cesarean section. AIDS 1997; 11: 1851-1857.
12. Abrams EJ, Matheson P, Thomas PA, Thea D, Krasinski K, Lambert G et al. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. Pediatrics 1995; 96: 451-458.
13. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ et al. Reduction of maternal-infant transmission of human immunodeficicency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-1180.
14. Eastman PS, Shapiro DE, Coombs RW, McSherry GD, Britto P, Herman SA et al. Maternal genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of HIV-1 in pediatric AIDS Clinical trial Group Protocol 076. J Infect Dis 1998; 577-564.
15. Matheson PB, Abrams EJ, Thomas P, Hernan MA, Thea DM, Lambert G et al. Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficicency virus type 1. J Infect Dis 1995;172: 353-358.
16. Simpson BJ, Shapiro DE, Andiman WA. Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J Acq Immune Def Syndr Hum Retrovirol 1997; 14:145-152.
17. Weiser B, Nachman S, Trapper P, Viscosi KH, Grimson R, Baxter G et al. Quantitation of human immunodeficiency virus type 1 during pregnancy; relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci 1994; 91: 8037-8041.
18. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, Mc Sherry GD et al. Maternal viral load, zidovudine treatment and the risk of transmission of human immunodeficicency virus from mothers to infant. N Engl J Med 1996; 335: 1621-1629.
19. Coll O, Hernández M, Boucher C, Fortuny C, Tejada BM, Canet Y et al. Viral load and HIV-1 vertical transmission. J Acq Immune Def Syndr Hum Retrovirol 1997; 14: 26-30.
20. Thea DM, Sketee RW, Bornshlegel K, Brown T, Orloff S, Matheson PB. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. AIDS 1997; 11: 437-444.
21. Mayaux MJ, Dussaix E, Isopet J, Rekacewicz C, Mandelbrot L, Vigneron NC et al. Maternal virus load during pregnancy and mother to child transmission of human immunodeficicency virus type 1: the French perinatal cohort studies. J Infect Dis 1997; 175: 172-175.
22. Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, Macken C et al. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nature Medicine 1997; 3: 549-552.
23. Aleixo LF, Goodenow MM, Sleasman JW. Zidovudine administered to women infected with human immunodeficicency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus. J Pediatr 1997; 130: 906-914.
24. Centers for Disease Control. Case control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood. France, United Kingdom and United States, January 1988-August 1994. MMWR 1995; 44: 929-933.
25. Bermúdez P, Moreno P, Delgado R, Ramos JT, Ruiz-Contreras J, Noriega AR. Detection of vertical transmission of human immunodeficicency virus type 1 by a commercial polymerase chain reaction assay. Eur J Clin Microbiol Infect Dis 1996; 15: 327-330.
26. Boyer PJ, Dillon M, Navaie M, Deveikes A, Keller M, O'Rourke SH et al. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis oz zidovudine guven during pregnancy and/or delivery. JAMA 1994; 271: 1925-1930.
27. Melvin AJ, Burchett SK, Watts DH, Hitti J, Hughes JP, McLellan et al. Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women. J Acq Immune Def Syndr 1997; 14: 232-236.
28. Fiscus SA, Adimora AA, Schoenbach VJ, Lim W, McKinney R, Rupar D et al. Importance of maternal ZDV therapy in the reduction of perinatal transmission of HIV. Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections [resumen 379]. Washington DC, enero de 1997.
29. Blanche S, Mayaux MJ, Mandelbrot L, Rouzioux C, Delfraissy JF, for the French Pediatric HIV infection Study Group Acceptability and impact of zidovudine prevention on mother to child transmission in France. Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections [resumen 380]. Washington DC, enero de 1997.
30. Quian M, Bui T, Ho RJY, Unadkat JD. Metabolism of 3'-azido-3'-deoxythymidine (ZDV) in human placental trophoblasts and Hofbaur cells. Biochem Pharmacol 1994; 48: 383-389.
31. Coll O, Omenaca F. Sociedad Espan̄ola de Ginecologia y Obstetricia, Asociación Española de Pediatría. Recomendaciones sobre el uso de zidovudina (ZDV) en la prevención de la transmisión vertical del VIH. An Esp Ped 1995; 42: 74-77.
32. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMRW 1998; 47:1-30.
33. Fortuny C, Sánchez E, Coll O, Jiménez González R. Transmisión vertical del virus de la inmunodeficiencia humana: seis an̄os de evolución (1987-1992). Med Clin (Barc) 1996; 107: 530-532.
34. th Interscience Conference on Antimicrobial Agents and Chemotherapy [resumen 1-118]. Toronto, septiembre de 1997.
35. Dunn DT, Brandt CD, Krivine A, Cassol SA, Roques P, Borkowsky W et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of infra-uterine and intra-partum transmission. AIDS 1995; 9: 7-11.
36. Bremer JW, Lew JF, Malobisky KP, Cooper E, Hillyer GW, Pitt J et al. Diagnosis of infection with human immunodeficicency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants Transmission Study. J Pediatr 1996; 129: 198-207.
37. Carpenter CJ, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA et al. Antiretroviral therapy for HIV infection in 1997 Updated recommendations of the international AIDS society-USA panel. JAMA 1997; 277: 1962-1969.